巨噬细胞与糖尿病的研究进展

doi:10.3969/j.issn.1003-9198.2021.12.005

[1] DONATH M Y, SHOELSON S E. Type 2 diabetes as an inflammatory disease[J]. Nat Rev Immunol,2011,11(2):98-107.
[2] EHSES J A, BÖNI-SCHNETZLER M, FAULENBACH M, et al. Macrophages, cytokines and beta-cell death in type 2 diabetes[J]. Biochem Soc Trans,2008,36(Pt 3):340-342.
[3] SHAPOURI-MOGHADDAM A, MOHAMMADIAN S, VAZINI H, et al. Macrophage plasticity, polarization, and function in health and disease[J]. J Cell Physiol, 2018, 233(9): 6425-6440.
[4] GINHOUX F, SCHULTZE J L, MURRAY P J, et al. New insights into the multidimensional concept of macrophage ontogeny, activation and function[J]. Nat Immunol, 2016, 17(1): 34-40.
[5] 王东,徐兴欣,范哲,等. 高糖环境下肾小管上皮细胞来源外泌体诱导巨噬细胞激活的作用与机制[J]. 中华肾脏病杂志,2018,34(9):681-688.
[6] ZENG H, QI X, XU X, et al. TAB1 regulates glycolysis and activation of macrophages in diabetic nephropathy[J]. Inflamm Res,2020,69(12):1215-1234.
[7] CALLE P, HOTTER G. Macrophage phenotype and fibrosis in diabetic nephropathy[J]. Int J Mol Sci, 2020,21(8):2806.
[8] HASEGAWA G, NAKANO K, SAWADA M, et al. Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy[J]. Kidney Int, 1991, 40(6):1007-1012.
[9] KALANTARINIA K, AWAD A S, SIRAGY H M. Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats[J]. Kidney Int, 2003, 64(4):1208-1213.
[10] WANG X, YAO B, WANG Y, et al. Macrophage cyclooxygenase-2 protects against development of diabetic nephropathy[J]. Diabetes, 2017, 66(2): 494-504.
[11] WANG Y, HARRIS D C. Macrophages in renal disease[J]. J Am Soc Nephrol, 2011, 22(1):21-27。
[12] OHKUMA T, KOMORITA Y, PETERS S A E, et al. Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals[J]. Diabetologia, 2019,62(9):1550-1560。
[13] ARONOW W S, AHN C. Incidence of heart failure in 2,737 older persons with and without diabetes mellitus[J]. Chest,1999,115(3):867-868.
[14] BUGGER H, ABEL E D. Molecular mechanisms of diabetic cardiomyopathy[J]. Diabetologia, 2014, 57(4):660-671.
[15] WATANABE R, HILHORST M, ZHANG H, et al. Glucose metabolism controls disease-specific signatures of macrophage effector functions[J]. JCI Insight, 2018, 3(20):e123047.
[16] MISHRA P K, YING W, NANDI S S, et al. Diabetic cardiomyopathy: an immunometabolic Perspective[J]. Front Endocrinol: Lausanne, 2017, 8:72.
[17] LASKIN D L. Macrophages and inflammatory mediators in chemical toxicity: a battle of forces[J]. Chem Res Toxicol, 2009, 22(8):1376-1385.
[18] MASER R E, STEENKISTE A R, DORMAN J S, et al. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study[J]. Diabetes, 1989, 38(11):1456-1461.
[19] SUN J J, TANG L, ZHAO X P, et al. Infiltration of blood-derived macrophages contributes to the development of diabetic neuropathy[J]. J Immunol Res, 2019, 2019:7597382.
[20] ROJEWSKA E, ZYCHOWSKA M, PIOTROWSKA A, et al. Involvement of macrophage inflammatory protein-1 family members in the development of diabetic neuropathy and their contribution to effectiveness of Morphine[J]. Front Immunol, 2018, 9:494.
[21] GONG J, LI J B, DONG H, et al. Inhibitory effects of berberine on proinfammatory M1 macrophage polarization through interfering with the interaction between TLR4 and MyD88[J]. BMC Complement Altern Med,2019, 19(1):314.
[22] SINDRILARU A, PETERS T, WIESCHALKA S, et al. An unrestrained proinfammatory M1 macrophage population induced by iron impairs wound healing in humans and mice[J]. J Clin Invest, 2011, 121(3):985-997.
[23] BOULTON A J, VINIK A I, AREZZO J C, et al. Diabetic neuropathies: a statement by the American Diabetes Association[J]. Diabetes Care, 2005,28(4):956-962.
[24] JACK M M, RYALS J M, WRIGHT D E. Protection from diabetes-induced peripheral sensory neuropathy--a role for elevated lyoxalase I? [J]. Exp Neurol, 2012, 234(1):62-69.
[25] NOH S U, LEE W Y, KIM W S, et al. Expression of macrophage migration inhibitory factor in footpad skin lesions with diabetic neuropathy[J]. Mol Pain, 2018, 14:1744806918775482.
[26] REN W, XI G, LI X, et al. Long non-coding RNA HCG18 promotes M1 macrophage polarization through regulating the miR-1 46a/TRAF6 axis, facilitating the progression of diabetic peripheral neuropathy[J]. Mol Cell Biochem, 2021, 476(1):471-482.
[27] ESSER N, LEGRAND-POELS S, PIETTE J, et al. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes[J]. Diabetes Res Clin Pract, 2014, 105(2):141-150.
[28] CHAWLA A, NGUYEN K D, GOH Y P. Macrophage-mediated inflammation in metabolic disease[J]. Nat Rev Immunol, 2011, 11(11):738-749.
[29] JEONG J H, LEE Y R, PARK H G, et al. The effects of either resveratrol or exercise on macrophage infiltration and switching from M1 to M2 in high fat diet mice[J]. J Exerc Nutrition Biochem, 2015, 19(2):65-72.
[30] MCARDLE M A, FINUCANE O M, CONNAUGHTON R M, et al. Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies[J]. Front Endocrinol: Lausanne, 2013, 4:52.
[31] XU L, OTA T. Emerging roles of SGLT2 inhibitors in obesity and insulin resistance: focus on fat browning and macrophage polarization[J]. Adipocyte, 2018,7(2):121-128.
[32] ACÍN-PÉREZ R, IBORRA S, MARTÍ-MATEOS Y, et al. Fgr kinase is required for proinflammatory macrophage activation during diet-induced obesity[J]. Nat Metab, 2020, 2(9):974-988.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Recommended 10

[1]	WANG Su, ZHAO Yijing, WEI Chenmin, CHEN Kun, CAO Wen, WANG Kun, YANG Yu. Correlation of triglyceride-glucose index with low-density lipoprotein subtypes in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2024, 38(10): 1002-1006.
[2]	GU Chonghuai, XIANG Xuejun, ZHENG Yuanxi, QIAO Rui, LIN Song. Efficacy of dapagliflozin in elderly patients undergoing coronary intervention with type 2 diabetes mellitus and ejection fraction reduced heart failure [J]. Practical Geriatrics, 2024, 38(10): 1025-1029.
[3]	. [J]. Practical Geriatrics, 2024, 38(10): 1066-1069.
[4]	LIU Qianhui, YAO Zijun, HE Yuli, XU Yunfan, WU Jun. Effects of HbA1c level on cardiac structure and function in elderly patients with type 2 diabetes mellitus and chronic heart failure [J]. Practical Geriatrics, 2024, 38(5): 491-437.
[5]	LIU Tongjun, ZHAO Yajie, HU Jieling, HU Yang, LIANG Wei. Effect of glucose metabolic disorders on serum levels of activin-A [J]. Practical Geriatrics, 2024, 38(5): 495-437.
[6]	. [J]. Practical Geriatrics, 2024, 38(5): 521-437.
[7]	. [J]. Practical Geriatrics, 2024, 38(5): 529-437.
[8]	TANG Yuan, DENG Shufang, HE Yongmei, DAI Yuxuan, LUO Jing. The status of health literacy and correlation with frailty in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2024, 38(3): 255-259.
[9]	DAI Ling-li, YU Yun. Association of estimated glomerular filtration rate with insulin resistance and β-cell function in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2023, 37(12): 1219-1223.
[10]	FAN Ting-yong, YUAN Li, YANG Xiao-ling, CHEN Qian. Assessment effect of Caprini scale on venous thromboembolism in elderly patients with diabetes [J]. Practical Geriatrics, 2023, 37(12): 1233-1237.
[11]	ZHANG He-cheng, WEI Su. Correlation of serum ferritin level with diabetic foot in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2023, 37(11): 1111-1114.
[12]	HU Yan, WU Hai-di, WANG Xue-fei, LOU Qing-lin, YE Qing, GU Liu-bao, DAI Jing, SONG Xiao-bo. Correlation between diabetic foot risk score and urinary microalbumin/creatinine ratio in elderly patients with type 2 diabetes [J]. Practical Geriatrics, 2023, 37(11): 1134-1137.
[13]	. [J]. Practical Geriatrics, 2023, 37(11): 1170-1175.
[14]	ZHANG Lin-ying, MEI Qun-chao, ZHANG Wei-qi, HU Yi-lan. Application of resistance training combined with high milk protein nutrition in elderly patients with type 2 diabetes mellitus and sarcopenia [J]. Practical Geriatrics, 2023, 37(10): 995-999.
[15]	. [J]. Practical Geriatrics, 2023, 37(10): 1064-1068.